What is Venous Thromboembolism?

 

Venous Thromboembolism (VTE) Market
Venous Thromboembolism

Venous thromboembolism (VTE), according to the International Society on Thrombosis and Hemostasis, Inc., is a major cause of death and disability globally. Annually, there are about 10 million cases of venous thromboembolism. The term VTE describes the development of blood clots in veins. A clot in the lungs is known as a pulmonary embolism, but one in a deep vein (often the leg) is known as deep vein thrombosis.

Deep Vein Thrombosis and Pulmonary Embolism (DVT/PE) are significant, but treatable, medical diseases that are frequently underdiagnosed. When a blood clot develops in a deep vein, a condition known as deep vein thrombosis (DVT) takes place. These clots can form in the arm, although most typically form in the lower leg, thigh, or pelvis. DVT is something that everyone should be aware of because it can result in significant disease, disability, and in very extreme situations, death. The good news is that DVT can be treated and prevented if caught early.

Although pulmonary embolism, in particular, is frequently disregarded as a serious public health issue, it is the most frequent preventable cause of death for hospital patients in the United States. Preventing VTE has significant promise for improving public health. According to data from randomised trials including general surgery patients, high-risk patients who receive effective preventive interventions can avoid Venous Thromboembolism in one out of every ten cases and save the lives of one out of every 200 patients.

Comments

Popular posts from this blog

The Art of Sabrage: Opening Champagne Bottles in Style

Enhancing Energy Efficiency with Silicone Sealants in Buildings

Choosing the Right Stock Music for Your Corporate Presentations